Limited Duration Loncastuximab Tesirine with Rituximab Induces High Complete Metabolic Response Rate in High-Risk Relapsed/Refractory Follicular Lymphoma - a Phase 2 StudyJuan Pablo Alderuccio,Alvaro J. Alencar,Jonathan H. Schatz,Russ Kuker, Georgio Pongas,Isildinha M. Reis,Jay Y. Spiegel, Laura Medina Andara,Lazaros J. Lekakis, Joseph S. Gyedu,Jose Sandoval-Sus,Amer M. Beitinjaneh, Nathalie Padron,Izidore S. Lossos,Joseph D. Rosenblatt, David S. Lessen,Craig H. MoskowitzBLOOD(2023)引用 0|浏览0暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要